%0 Journal Article %1 Boissel2007 %A Boissel, Jean-Pierre %D 2007 %J Fundamental & clinical pharmacology %K AnticholesteremicAgents AnticholesteremicAgents:administration&dosage AnticholesteremicAgents:therapeuticuse Cholesterol Cholesterol:blood ClinicalProtocols DataInterpretation Dose-ResponseRelationship Drug HeptanoicAcids HeptanoicAcids:administration&dosage HeptanoicAcids:therapeuticuse Humans Models Pyrroles Pyrroles:administration&dosage Pyrroles:therapeuticuse RandomizedControlledTrialsasTopic:statistics ResearchDesign Statistical RCT %N 2 %P 155-6 %R 10.1111/j.1472-8206.2007.00478.x %T How to deal with multiple treatment or dose groups in randomized clinical trials? Another approach. %U http://www.ncbi.nlm.nih.gov/pubmed/17391287 %V 21 %X The multiple test issue is a tricky one. There is no entirely correct solution. It is better to avoid it by careful thinking prior to beginning the experiment. In fundamental and clinical pharmacology, there are several established concepts that allow researchers to minimize the cases where the issue arises. %@ 0767-3981

@article{Boissel2007, abstract = {The multiple test issue is a tricky one. There is no entirely correct solution. It is better to avoid it by careful thinking prior to beginning the experiment. In fundamental and clinical pharmacology, there are several established concepts that allow researchers to minimize the cases where the issue arises.}, added-at = {2023-02-03T11:44:35.000+0100}, author = {Boissel, Jean-Pierre}, biburl = {https://www.bibsonomy.org/bibtex/283968fb3f226947b411ff9d71b3bab4c/jepcastel}, doi = {10.1111/j.1472-8206.2007.00478.x}, interhash = {773e9e7ae761933aa89a782b9df9b759}, intrahash = {83968fb3f226947b411ff9d71b3bab4c}, isbn = {0767-3981}, issn = {0767-3981}, journal = {Fundamental & clinical pharmacology}, keywords = {AnticholesteremicAgents AnticholesteremicAgents:administration&dosage AnticholesteremicAgents:therapeuticuse Cholesterol Cholesterol:blood ClinicalProtocols DataInterpretation Dose-ResponseRelationship Drug HeptanoicAcids HeptanoicAcids:administration&dosage HeptanoicAcids:therapeuticuse Humans Models Pyrroles Pyrroles:administration&dosage Pyrroles:therapeuticuse RandomizedControlledTrialsasTopic:statistics ResearchDesign Statistical RCT}, month = {4}, note = {4215<m:linebreak></m:linebreak>PUBM: Print; JID: 8710411; 0 (Anticholesteremic Agents); 0 (Heptanoic Acids); 0 (Pyrroles); 110862-48-1 (atorvastatin); 57-88-5 (Cholesterol); CON: Fundam Clin Pharmacol. 2007 Apr;21(2):137-54. PMID: 17391286; ppublish;<m:linebreak></m:linebreak>Comparacions múltiples}, number = 2, pages = {155-6}, pmid = {17391287}, timestamp = {2023-05-04T09:00:45.000+0200}, title = {How to deal with multiple treatment or dose groups in randomized clinical trials? Another approach.}, url = {http://www.ncbi.nlm.nih.gov/pubmed/17391287}, volume = 21, year = 2007 }